A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis

A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vigamox in the Treatment of Bacterial Conjunctivitis

This is a study to investigate a novel drug candidate for the treatment of bacterial conjunctivitis.

Inclusion Criteria:

• Clinical diagnosis of acute bacterial conjunctivitis and exhibit purulent conjunctival discharge and redness in at least one eye.

Exclusion Criteria:

• Pregnant or nursing females.
• Use of any antibiotic within 72 hours of enrollment.
• Any disease conditions that could interfere with the safety and efficacy evaluations of the study drug.
• Participation in an ophthalmic drug or device research study within 30 days prior to entry into this study.